INFLIXIMAB BETA
UNII X95ZTP4AEK

Substance Identification & Data

This profile provides standardized clinical and technical data for Infliximab Beta, uniquely identified by the FDA Unique Ingredient Identifier (UNII) X95ZTP4AEK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2639475-46-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
X95ZTP4AEK
CAS Registry Number
2639475-46-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
INFLIXIMAB BETA
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C215272
National Cancer Institute reference terminology for clinical and research data.
INN ID
13096
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Infliximab Beta. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

INFLIXIMAB BETA

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN CHIMERIC (1-450) (VH (MUS MUSCULUS IGHV6-6*02 (89.0%) -(IGHD) -IGHJ2*01 (92.9%), CDR-IMGT (8.10.11) (26-33.51-60.99-109)) (1-120) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (217) (121-218), HINGE 1-15 (219-233), CH2 (234-343), CH3 D12 (359), L14 (361) (344-448), CHS (449-450)) (121-450)), (223-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN CHIMERIC (1'-214') (V-KAPPA (MUS MUSCULUS IGKV5-48*01 (93.7%) -IGKJ4*01 (83.3%) K123>N (103'), I126>V (106'), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')); DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-S, GLYCOFORM ALFA
HUMANIZED RECOMBINANT ANTI-TUMOR NECROSIS FACTOR ? MONOCLONAL ANTIBODY
IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR .ALPHA.) (HUMAN-MUS MUSCULUS MONOCLONAL XTMAB-16 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL XTMAB-16 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TNF (TUMOR NECROSIS FACTOR, TNF SUPERFAMILY MEMBER 2, TNFSF2, TNF-ALPHA, TNFA)), CHIMERIC MONOCLONAL ANTIBODY (INFLIXIMAB BETA)
INFLIXIMAB BETA [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus